Impact of nutraceuticals on markers of systemic inflammation

Impact of nutraceuticals on markers of systemic inflammation

Role of omega-6 and omega-3 fatty acids on inflammatory pathways Based on the available evidence, we are able to delineate specific nutraceuticals that may be important in reducing markers of inflammatory response. ILEP Experts discussed the impact of nutraceuticals on the induction of inflammation. The paper can be accessed here.

Potential benefit of colchicine in reducing cardiovascular events

Potential benefit of colchicine in reducing cardiovascular events

ILEP Experts would like to present a meta-analysis conducted to test and determine the potential benefit in reducing cardiovascular events from administration of colchicine in patients with coronary artery disease. The results of the study bring valuable knowledge related to this alkaloid and its use. You can read the publication here.

Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases – A position paper from the International Lipid Expert Panel (ILEP)

Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases – A position paper from the International Lipid Expert Panel (ILEP)

Massimiliano Ruscica, Peter E Penson, Nicola Ferri, Cesare R Sirtori, Matteo Pirro, G B John Mancini, Naveed Sattar, Peter P Toth, Amirhossein Sahebkar, Carl J Lavie, Nathan D Wong, Maciej Banach; International Lipid Expert Panel (ILEP) and International Lipid Expert Panel Experts (alphabetically)

Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies

Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies

Kamal Awad, Maged Mohammed, Mahmoud Mohamed Zaki, Abdelrahman I Abushouk, Gregory Y H Lip, Michael J Blaha, Carl J Lavie, Peter P Toth, J Wouter Jukema, Naveed Sattar, Maciej Banach; Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group and the International Lipid Expert Panel (ILEP)

The International Lipid Expert Panel (ILEP)— the role of ‘optimal’ collaboration in the effective diagnosis and treatment of lipid disorders

The International Lipid Expert Panel (ILEP)— the role of ‘optimal’ collaboration in the effective diagnosis and treatment of lipid disorders

When prof. Maciej Banach founded the International Lipid Expert Panel (ILEP) in 2015 he probably did not expect that just after 6 years it will be a worldwide recognized group of experts and simultaneously – very close friends– from almost 100 countries, working together to improve diagnosis and therapy especially in the countries, when optimal management in the field of preventive cardiology and lipid disorders is still a great challenge (e.g. CEE, SE & Asian countries). ILEP was founded in order to […]

New paper on how to manage with hyperlipidemia

New paper on how to manage with hyperlipidemia

See the attempt at #recommendations on how to manage with #hyperlipidemia in #ACS pts we prepared with #Experts from #CEE&SE #countries – an effect of our hard work since May 2020! I hope it adds a lot to the discussion on the role of #lipid #lowering combination therapy. To the best of my knowledge, these […]

See the results of the largest ever #reallife analysis on red yeast rice (#RYR) preparations’ #safety (2.3 million #consumers).

See the results of the largest ever #reallife analysis on red yeast rice (#RYR) preparations’ #safety (2.3 million #consumers).

See the results of the largest ever #reallife analysis on red yeast rice (#RYR) preparations’ #safety (2.3 million #consumers). We confirmed that RYR is very safe – the total reporting rate of #AEs was estimated to be 0.037%. Of the 542 reported cases, 21 (0.0009% of exposed consumers) included suspected serious adverse events (#SAEs). After […]